Work

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy

Year: 2003

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-003-0435-2

Authors: Zane C. Neal, Michael Imboden, Alexander L. Rakhmilevich, Kyung-Mann Kim, Jacquelyn A. Hank, Jean Surfus, John R. Dixon, Holger N. Lode, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Scripps Research Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1415676599, G2649204724, G42679306, Clinical Development of HU14.18-IL2 Targeted Therapy

OpenAlex ID: W2012546917

FWCI: 0.728

Cites: 64

Cited by: 48

Related to: 10